Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy

Haematologica. 2023 Dec 1;108(12):3433-3437. doi: 10.3324/haematol.2022.282345.

Authors

Affiliations

¹ Dana-Farber Cancer Institute, Boston, MA. [email protected].
² Dana-Farber Cancer Institute, Boston, MA.
³ City of Hope National Medical Center, Duarte, CA.
⁴ Fred Hutchinson Cancer Research Center, Seattle, WA; University of Washington, Seattle, WA.
⁵ University of Chicago, Chicago, IL.
⁶ Emory University, Atlanta, GA.
⁷ University Hospital of Rennes, Rennes.
⁸ Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD19
Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / methods
Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
Lymphoma, Large B-Cell, Diffuse* / therapy
Positron-Emission Tomography
Prognosis
Receptors, Antigen, T-Cell / genetics
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen
Antigens, CD19
Receptors, Antigen, T-Cell